Telehealth Delivered Home-based Walking for Vets With Peripheral Artery Disease
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- VA Office of Research and Development
- Study ID
- NCT06033924
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 21 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Walking Program: Internet-based — BEHAVIORALInternet pages allow participants to see step-count goals, progress over time and access to walking tips for 12 weeks. Among participants who do not increase their step counts (\>15%), these non-responders will be rerandomized to received the combination of internet and telehealth or either along for an additional 12-weeks (total intervention time is 24-weeks). A follow-up phase of 12-weeks will be completed for a total participant duration of 36 weeks.
- Walking Program: Telehealth-based — BEHAVIORALTelehealth sessions allow participants review step-count goals, progress over time and access to walking tips with the study coordinator for 12 weeks. Among participants who do not increase their step counts (\>15%), these non-responders will be rerandomized to received the combination of internet and telehealth or either along for an additional 12-weeks (total intervention time is 24-weeks). A follow-up phase of 12-weeks will be completed for a total participant duration of 36 weeks.
Study Details
Walking is beneficial for adults with peripheral arterial disease. Benefits include the ability to walk for longer periods and general well being (quality of life). This study will look at two types of delivery methods for a home-based walking program. The walking program includes step count goals, information on healthy walking and motivational messages. The two delivery methods include a web-based delivery and an telehealth delivery. Participants are randomized to either one of the delivery methods or usual care. After 12 weeks participants in the web based or telehealth based groups maybe re-randomized to receive a combination of both web-based and telehealth for a second 12 week period. After 24 weeks, everyone is followed for an additional 12 weeks, so the total time a participant is in the study is 36 weeks. At baseline, 12, 24 and 36 weeks the investigators ask participant to walk (slowly) on a treadmill, perform a six-minute walk test, and several questionnaires on quality of life. Vouchers are provided at each study visit. All participants who complete the study also keep their pedometer.
Key Dates
- Start date
- Jul 1, 2024
- Status verified
- Apr 2026
- Primary completion
- Oct 29, 2027
- Completion
- Oct 29, 2027
Study Design
- Enrollment
- 225 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Internet-based Walking ProgramInternet pages allow participants to see step-count goals, progress over time and access to walking tips
- Experimental: Telehealth Counseling Walking ProgramTelehealth sessions allow participants review step-count goals, progress over time and access to walking tips with the study coordinator
Primary Outcome Measure
Change in maximal walking distance [ Time Frame: baseline to 12 weeks ]
Central Contacts
- Elizabeth A Jackson, MD(205) 933-8101
- Megan A Baker, BS(205) 240-6552
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Birmingham VA Medical Center, Birmingham, AL | Birmingham | Alabama | 35233-1927 | Elizabeth A Jackson, MD (PRINCIPAL_INVESTIGATOR) |
| VA Palo Alto Health Care System, Palo Alto, CA | Palo Alto | California | 94304-1207 | |
| Rocky Mountain Regional VA Medical Center, Aurora, CO | Aurora | Colorado | 80045-7211 |
Find similar trials in Birmingham, AL
Related Studies
- Optimizing Gait Rehabilitation for Veterans With Non-traumatic Lower Limb AmputationRecruiting · VA Office of Research and Development · Aurora, Colorado
- The THOR IDE StudyRecruiting · Philips Clinical & Medical Affairs Global · St. Helena, California
- Improving Mobility After Revascularization in Peripheral Artery DiseasePHASE3 · Recruiting · Northwestern University · Tucson, Arizona
- Red Light Treatment in Peripheral Artery DiseaseRecruiting · University of Alabama at Birmingham · Milwaukee, Wisconsin